证券记录 · 已归档季度
RVTY
Revvity, Inc. · Healthcare · Medical - Diagnostics & Research
12被追踪持有人
-1Δ持有人
20.50M持有股份
$2.17B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -7.7% ·
股份流向 +13.2% ·
净新建仓位 -8.3%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 133 | +9 | 66.02M | $7.35B | +14 | −4 |
| Q1 2026 | 126 | -7 | 72.99M | $6.39B | +4 | −12 |
| Q4 2025 | 133 | 0 | 75.39M | $7.30B | +3 | −2 |
| Q3 2025 | 19 | +1 | 44.69M | $3.92B | +1 | −1 |
| Q2 2025 | 16 | +1 | 42.02M | $4.06B | +3 | −2 |
| Q1 2025 | 12 | -1 | 20.50M | $2.17B | — | −1 |
| Q4 2024 | 13 | 0 | 18.11M | $2.02B | +1 | −1 |
| Q3 2024 | 12 | -1 | 11.86M | $1.51B | +1 | −2 |
| Q2 2024 | 13 | — | 11.86M | $1.24B | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 9.56M | +25.3% | $1.01B | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 9.56M | +25.3% | $1.01B | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (被动) | 5.17M | 0.0% | $546.78M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 2.99M | +3.2% | $315.67M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 2.99M | +3.2% | $315.67M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Norges Bank ✦ (被动) | 1.24M | +8.4% | $131.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | PRIMECAP Management ✦ | 1.15M | +20.4% | $121.20M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 8 | Adage Capital Partners ✦ | 111.09K | +187.1% | $11.75M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Gotham Asset Management ✦ | 108.35K | -33.8% | $11.46M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 69.40K | +102.0% | $7.34M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Fisher Asset Management ✦ | 62.02K | +8.3% | $6.56M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Wellington Management ✦ | 22.54K | +238.7% | $2.38M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Wellington Management ✦ | 22.54K | +238.7% | $2.38M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 8.45K | +5.2% | $882,549 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 8.45K | +5.2% | $882,549 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 8.45K | +5.2% | $882,549 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 8.45K | +5.2% | $882,549 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Marshall Wace ✦ | 2.92K | -17.9% | $308,936 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Citadel Advisors | $455,480 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 495 持有人, 115.11M 股份, $7.19B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
Aug 14
SC 13G/A — T. Rowe Price Investment Management…
Aug 14
SC 13G/A — PRICE T ROWE ASSOCIATES INC /MD/
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据